Search research articles
Contact Us
Filters
Showing results (91-100 of 173) with videos related to
Page
of 18
Sort By:
Plos Pathogens
|
June 20, 2014
Biogenesis of influenza a virus hemagglutinin cross-protective stem epitopes
Javier G Magadán, Meghan O Altman, William L Ince, et al.
Briefings in Bioinformatics
|
February 19, 2022
Librator: a platform for the optimized analysis, design, and expression of mutable influenza viral antigens
Lei Li, Siriruk Changrob, Yanbin Fu, et al.
Vaccine
|
March 20, 2012
Human monoclonal antibodies generated following vaccination with AVA provide neutralization by blocking furin cleavage but not by preventing oligomerization
Kenneth Smith, Sherry R Crowe, Lori Garman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 5, 2016
Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus
Wenqian He, Gene S Tan, Caitlin E Mullarkey, et al.
Mbio
|
June 1, 2012
Antibody pressure by a human monoclonal antibody targeting the 2009 pandemic H1N1 virus hemagglutinin drives the emergence of a virus with increased virulence in mice
Christopher D O'Donnell, Leatrice Vogel, Amber Wright, et al.
The Journal of Experimental Medicine
|
December 24, 2008
Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors
J Andrew Duty, Peter Szodoray, Nai-Ying Zheng, et al.
Cell Reports
|
December 26, 2019
Identification of Antibodies Targeting the H3N2 Hemagglutinin Receptor Binding Site following Vaccination of Humans
Seth J Zost, Juhye Lee, Megan E Gumina, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 30, 2016
Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus
Lalita Priyamvada, Kendra M Quicke, William H Hudson, et al.
Mbio
|
June 15, 2021
An Egg-Derived Sulfated <i>N</i>-Acetyllactosamine Glycan Is an Antigenic Decoy of Influenza Virus Vaccines
Jenna J Guthmiller, Henry A Utset, Carole Henry, et al.
Elife
|
August 28, 2019
Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin
Juhye M Lee, Rachel Eguia, Seth J Zost, et al.
Page
of 18
Search research articles
Search
Showing results (91-100 of 173) with videos related to
Sort By:
Page
of 18
Plos Pathogens
|
June 20, 2014
Biogenesis of influenza a virus hemagglutinin cross-protective stem epitopes
Javier G Magadán, Meghan O Altman, William L Ince, et al.
Briefings in Bioinformatics
|
February 19, 2022
Librator: a platform for the optimized analysis, design, and expression of mutable influenza viral antigens
Lei Li, Siriruk Changrob, Yanbin Fu, et al.
Vaccine
|
March 20, 2012
Human monoclonal antibodies generated following vaccination with AVA provide neutralization by blocking furin cleavage but not by preventing oligomerization
Kenneth Smith, Sherry R Crowe, Lori Garman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 5, 2016
Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus
Wenqian He, Gene S Tan, Caitlin E Mullarkey, et al.
Mbio
|
June 1, 2012
Antibody pressure by a human monoclonal antibody targeting the 2009 pandemic H1N1 virus hemagglutinin drives the emergence of a virus with increased virulence in mice
Christopher D O'Donnell, Leatrice Vogel, Amber Wright, et al.
The Journal of Experimental Medicine
|
December 24, 2008
Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors
J Andrew Duty, Peter Szodoray, Nai-Ying Zheng, et al.
Cell Reports
|
December 26, 2019
Identification of Antibodies Targeting the H3N2 Hemagglutinin Receptor Binding Site following Vaccination of Humans
Seth J Zost, Juhye Lee, Megan E Gumina, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 30, 2016
Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus
Lalita Priyamvada, Kendra M Quicke, William H Hudson, et al.
Mbio
|
June 15, 2021
An Egg-Derived Sulfated <i>N</i>-Acetyllactosamine Glycan Is an Antigenic Decoy of Influenza Virus Vaccines
Jenna J Guthmiller, Henry A Utset, Carole Henry, et al.
Elife
|
August 28, 2019
Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin
Juhye M Lee, Rachel Eguia, Seth J Zost, et al.
Page
of 18